|
|
Volumn 748, Issue 1, 2000, Pages 21-30
|
|
Factors to consider in the development of generic bioanalytical high-performance liquid chromatographic-mass spectrometric methods to support drug discovery
a
|
|
Author keywords
Drugs; ESI; HPLC; Ion suppression; Isotopes; Mobile phase
|
|
Indexed keywords
CAFFEINE;
DRUG;
FENFLURAMINE;
GALACTOSIDE;
LEVAMISOLE;
PARACETAMOL;
PENTAMIDINE;
PIPAZETATE;
TOLBUTAMIDE;
WARFARIN;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
COMPUTER PROGRAM;
DATA ANALYSIS;
DRUG DETERMINATION;
DRUG IDENTIFICATION;
DRUG MIXTURE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
INSTRUMENT;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
SPECTROPHOTOMETRY, ULTRAVIOLET;
|
|
EID: 0034306633
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(00)00319-4 Document Type: Article |
|
Times cited : (58)
|
|
References (11)
|
